|4Apr 19, 9:15 PM ET

Islam Khalid 4

4 · Processa Pharmaceuticals, Inc. · Filed Apr 19, 2022

Insider Transaction Report

Form 4
Period: 2022-03-15
Islam Khalid
Director
Transactions
  • Award

    Restricted Stock

    2022-01-01+18,20818,208 total
    Exercise: $0.00Common Stock (18,208 underlying)
Footnotes (1)
  • [F1]Restricted stock units vest 100% on December 31, 2022.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4